Seth Klarman - Baupost Group
As of Q2 2026, Seth Klarman reported 23 long-equity positions worth $5.42B in aggregate.
Copy-investor backtest
- Latest quarter
- +3.22%
- 1-year
- +20.94%
- 3-year
- +48.31%
- 5-year
- +12.01%
- 3-year vs S&P 500
- -25.70%
- 5-year vs S&P 500
- -61.90%
- 5-year top 5
- -0.29%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Seth Klarman files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 12 of 39 rows. Rows without a quote are marked unavailable.
| 1 | FOXA | TWENTY FIRST CENTY FOX INC | 17.64% | Add +48.2% | 39,415,829 | $1.96B | $49.69 | No quote |
| 2 | SYF | SYNCHRONY FINL | 8.81% | - | 29,295,030 | $977.87M | $33.38 | No quote |
| 3 | LNG | CHENIERE ENERGY INC | 8.34% | Reduce -31.5% | 14,196,135 | $925.45M | No quote | No quote |
| 4 | VSAT | VIASAT INC | 8.13% | Add +0.5% | 13,732,068 | $902.47M | $65.72 | No quote |
| 5 | QRVO | QORVO INC | 7.94% | - | 11,000,000 | $881.87M | $80.17 | No quote |
| 6 | AGN | ALLERGAN PLC | 7.43% | Add +4.2% | 4,950,000 | $825.26M | No quote | No quote |
| 7 | PXD | PIONEER NAT RES CO | 6.82% | - | 4,000,000 | $756.96M | No quote | No quote |
| 8 | FOX | TWENTY FIRST CENTY FOX INC | 6.04% | Add +19.0% | 13,606,260 | $670.38M | $49.27 | No quote |
| 9 | AR | ANTERO RES CORP | 5.11% | - | 26,587,791 | $567.65M | $21.35 | No quote |
| 10 | CLNY | COLONY CAP INC NEW | 2.79% | New | 49,687,370 | $310.05M | No quote | No quote |
| 11 | T | AT&T INC | 2.74% | New | 9,480,700 | $304.43M | $32.11 | No quote |
| 12 | CAH | CARDINAL HEALTH INC | 2.24% | - | 5,100,000 | $249.03M | $48.83 | No quote |
| 13 | ATRA | ATARA BIOTHERAPEUTICS INC | 2.07% | - | 6,254,632 | $229.86M | No quote | No quote |
| 14 | MCK | MCKESSON CORP | 1.96% | Add +0.7% | 1,627,700 | $217.14M | $133.40 | No quote |
| 15 | TBPH | THERAVANCE BIOPHARMA INC | 1.90% | - | 9,309,168 | $211.13M | No quote | No quote |
| 16 | PCG | PG&E CORP | 1.73% | Add +42.9% | 4,500,000 | $191.52M | $42.56 | No quote |
| 17 | COR | AMERISOURCEBERGEN CORP | 1.44% | Add +42.2% | 1,873,565 | $159.76M | No quote | No quote |
| 18 | VRTV | VERITIV CORP | 1.37% | - | 3,824,385 | $152.4M | No quote | No quote |
| 19 | TRCO | TRIBUNE MEDIA CO | 1.03% | New | 2,996,042 | $114.66M | No quote | No quote |
| 20 | KERX | KERYX BIOPHARMACEUTICALS INC | 0.87% | - | 25,791,678 | $96.98M | No quote | No quote |
| 21 | SBGI | SINCLAIR BROADCAST GROUP INC | 0.74% | New | 2,571,302 | $82.67M | $32.15 | No quote |
| 22 | AMC | AMC ENTMT HLDGS INC | 0.72% | - | 5,000,000 | $79.5M | No quote | No quote |
| 23 | NG | NOVAGOLD RES INC | 0.54% | - | 13,467,145 | $59.93M | $4.45 | No quote |
| 24 | GTYHU | GTY TECHNOLOGY HOLDINGS INC | 0.41% | - | 4,400,000 | $45.89M | No quote | No quote |
| 25 | PRTK | PARATEK PHARMACEUTICALS INC | 0.22% | - | 2,394,498 | $24.42M | No quote | No quote |
| 26 | TBIO | TRANSLATE BIO INC | 0.22% | New | 1,923,076 | $24.33M | No quote | No quote |
| 27 | SCAC | SABAN CAP ACQUISITION CORP | 0.21% | - | 2,326,500 | $23.45M | No quote | No quote |
| 28 | TMQ | TRILOGY METALS INC NEW | 0.21% | Add +23.1% | 13,050,758 | $23.17M | No quote | No quote |
| 29 | SHPG | SHIRE PLC | 0.15% | New | 98,932 | $16.7M | No quote | No quote |
| 30 | STNLU | SENTINEL ENERGY SVCS INC | 0.15% | - | 1,600,000 | $16.14M | No quote | No quote |
| 31 | SCACW | SABAN CAP ACQUISITION CORP | 0.01% | - | 1,163,250 | $1.4M | No quote | No quote |
| 37 | TWX | TIME WARNER INC | - | Sold | 0 | $0 | No quote | No quote |
| 36 | PBF | PBF ENERGY INC | - | Sold | 0 | $0 | No quote | No quote |
| 35 | OREX | OREXIGEN THERAPEUTICS INC | - | Sold | 0 | $0 | No quote | No quote |
| 34 | FWP | FORWARD PHARMA A/S | - | Sold | 0 | $0 | No quote | No quote |
| 33 | CLNS | COLONY NORTHSTAR INC | - | Sold | 0 | $0 | No quote | No quote |
| 32 | IMOS | CHIPMOS TECHNOLOGIES INC | - | Sold | 0 | $0 | No quote | No quote |
Other instruments
Bonds, warrants, or non-share principal positions reported alongside the equity portfolio.
| 1 | TSLA 2.375 03/15/22 | TESLA INCNOTE 2.375% 3/1 | OTHER | 250,000,000 | $306.25M |
| 2 | TBPH 3.25 11/01/23 | THERAVANCE BIOPHARMA INCNOTE 3.250%11/0 | OTHER | 30,000,000 | $29.96M |